Eagle Capital Management (New York)
BIIB icon

Eagle Capital Management (New York)’s Biogen BIIB Stock Holding History

Eagle Capital Management (New York)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,600
Closed -$823K – 59
2020
Q1 		$823K Buy
+2,600
New +$789K ﹤0.01% 53

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Eagle Capital Management (New York)'s BIIB Position: Q2 2020 in Review

Eagle Capital Management (New York) sold out of Biogen (BIIB) in Q2 2020, closing a stake of 2,600 shares — an estimated $823K sold.

Eagle Capital Management (New York) first reported a position in BIIB in Q1 2020 and held it in 1 quarter. The position peaked at $823K in Q1 2020. 1,059 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • Eagle Capital Management (New York) reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
  • Eagle Capital Management (New York) sold 2,600 Biogen shares in Q2 2020, an estimated $823K.
  • Eagle Capital Management (New York) first reported a position in Biogen in Q1 2020 and held it in 1 quarter.
  • Eagle Capital Management (New York)'s Biogen position peaked at $823K in Q1 2020.
  • 1,059 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Eagle Capital Management (New York)'s 13F filing for Q2 2020, filed 14 Aug 2020.